Purchase Order 75N95023P00856
Award Date 9/19/23
Potential Completion Date 9/18/24
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to customize software, hardware, and probes for use in implanting devices into rat brains and conducting neural recordings. The contract supports research being conducted by Dr. Schoenbaum at the National Institute on Drug Abuse, part of the Department of Health and Human Services, to advance understanding of...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a firm fixed price purchase order valued at twenty-five thousand dollars by the National Institutes of Health's National Institute on Drug Abuse. Under this contract, Nuvectra will customize software, hardware, and neural probes for implanting into rat brains and conducting neural recordings over a one year period ending in September 2024. The goal of this work supports the National Institute on Drug Abuse's broader...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for Nuvectra to provide customization of software to support NIDA's research efforts. Work will be performed in Baltimore, Maryland over a one-year period concluding in September 2024. No subcontractors...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $75,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for Nuvectra to provide an X-DAQ ONE Series electrophysiology recording system, including hardware, software, and silicon recording probes, to support NIDA's biomedical research efforts. Performance...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse, a component of the National Institutes of Health within the Department of Health and Human Services. Under the contract, Nuvectra will provide Microelectrode PCB Adaptors and Passive Commutators to support scientific research. The adaptors and commutators will facilitate HDMI and UHDMI connections for use with X-Series equipment....
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Neuronexus Technologies, Inc., doing business as Nuvectra. The purpose of this $24,999.00 contract is to procure neural recording probes from Neuronexus that will be used for implanting into rat brains as part of the agency's research efforts. The contract has an ultimate completion date of December 9, 2025. Neuronexus is a...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,978.26 firm fixed price purchase order to Neuronexus Technologies, Inc., doing business as Nuvectra, for data acquisition printed circuit boards to support scientific research. The contract has a period of performance of September 7, 2023 through September 6, 2024. Place of performance will be Nuvectra's facilities in Baltimore, Maryland. No set aside designation or...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Neuronexus Technologies, Inc., doing business as Nuvectra. The $23,736.41 contract is for the administrative de-obligation of unexpended and expiring Fiscal Year 2020 funding in preparation for the September 30, 2025 closing of the period of availability for these funds, as required by 31 U.S.C. Section 1552(a). The contract is for the...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $24,232.52 firm fixed-price purchase order by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to deliver X-HEADSTAGE-X6R128-UHDMI-M-ACC neuroscience research equipment. As the prime contractor, Nuvectra will provide the specified headstage products to support the NIH institute's biomedical research efforts. No subcontractors or set-aside designations were...
- Neuronexus Technologies, Inc. (also doing business as Nuvectra) was awarded a firm fixed-price purchase order valued at $24,097.09 by the National Institute of Mental Health (NIMH) on January 20, 2026. The contract, which carries no set-aside designation, is scheduled for completion by January 19, 2027, with performance taking place at the company's facility in Ann Arbor, Michigan. As a specialized manufacturer of advanced neuroscience research equipment, Neuronexus will deliver products or...